Cost-effectiveness of pathogen reduction technology for plasma and platelets in Québec: A focus on potential emerging pathogens.

Grégoire, Yves; Delage, Gilles; Custer, Brian; Rochette, Samuel; Renaud, Christian; Lewin, Antoine; Germain, Marc

Grégoire, Yves; Delage, Gilles; Custer, Brian; Rochette, Samuel; Renaud, Christian; Lewin, Antoine; Germain, Marc.

Affiliation

Grégoire Y; Medical Affairs and Innovation, Héma-Québec, Québec city, Canada.
Delage G; Héma-Québec, Quebec City, Canada.
Custer B; Vitalant Research Institute, San Francisco, California, USA.
Rochette S; Department of Laboratory Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Renaud C; Héma-Québec, Quebec City, Canada.
Lewin A; Héma-Québec, Quebec City, Canada.
Germain M; Héma-Québec, Quebec City, Canada.

Transfusion ; 62(6): 1208-1217, 2022 06.

Article in En | MEDLINE | ID: mdl-35560238

Subject(s)

Blood Platelets; West Nile virus; Cost-Benefit Analysis; Humans; Quality-Adjusted Life Years; Quebec; Technology

Key words

blood safety; cost analysis; transfusion reaction; transfusion-transmissible infection

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: West Nile virus / Blood Platelets Type of study: Health_economic_evaluation / Prognostic_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Transfusion Year: 2022 Type: Article Affiliation country: Canada

Fulltext

XML

PubMed Links

Search on Google